Insights
Search Results
Client Highlights
6.02.26
Wilson Sonsini Advises Contentful on Acquisition by Salesforce
On June 1, 2026, Salesforce, the world's No. 1 AI CRM, announced that it has signed a definitive agreement to acquire Contentful, a leading composable content platform trusted by over 4,800 of the world’s leading brands to deliver personalized digital experiences at scale. Wilson Sonsini Goodrich & Rosati advised Contentful on the transaction.
Client Highlights
4.14.26
Wilson Sonsini Advises Special Committee of the Board in Globalstar's Acquisition by Amazon
On April 14, 2026, Amazon and Globalstar announced they have entered into a definitive merger agreement under which Amazon will acquire Globalstar, a leading mobile satellite services (MSS) operator, a pioneer in non-geostationary orbit (NGSO) satellites and D2D technology, and a provider of critical and emergency communications to customers around the world. Wilson Sonsini Goodrich & Rosati is representing the special committee of Globalstar’s board of directors on the transaction.
Client Highlights
3.13.26
Wilson Sonsini Advises Urgently on Acquisition by Agero
On March 13, 2026, Agero, a software-enabled driver safety services and technology company, announced that it has entered into an agreement to acquire Urgent.ly (Urgently), a digital software platform that provides roadside and mobility assistance, for a cash price of $5.50 per share. The tender offer and merger are expected to close by the end of May 2026, subject to satisfaction of customary closing conditions. Wilson Sonsini Goodrich & Rosati advised Urgently on the transaction.
Client Highlights
2.25.26
Wilson Sonsini Advises SambaNova on $350 Million Series E Financing
On February 24, 2026, SambaNova, a leader in next‑generation AI infrastructure, announced that it has raised more than $350 million in investment from new and existing investors. The oversubscribed Series E round was led by Vista Equity Partners and Cambium Capital, with strong participation from Intel Capital. Wilson Sonsini Goodrich & Rosati advised SambaNova on the transaction.
Client Highlights
1.23.26
Wilson Sonsini Advises Brex on $5.15 Billion Acquisition by Capital One
On January 22, 2026, Capital One announced that it has entered into a definitive agreement to acquire Brex, in a combination of stock and cash transaction valued at $5.15 billion. Brex is a modern, AI-native software platform offering intelligent finance solutions that make it easy for businesses to issue corporate cards, automate expense management, and make secure, real-time payments. The transaction is expected to close in the middle of 2026, subject to customary closing conditions. Wilson Sonsini Goodrich & Rosati advised Brex on the transaction.
Client Highlights
1.07.26
Wilson Sonsini Advises OneStream on Acquisition by Hg
On January 6, 2026, OneStream, the leading enterprise finance management platform, announced that it has entered into a definitive agreement to be acquired by Hg, a leading investor in software, services, and data businesses. The all-cash transaction values OneStream at approximately $6.4 billion in equity value. Wilson Sonsini Goodrich & Rosati advised OneStream on this transaction in a continuation of its long-standing advisory relationship with the company, including leading OneStream’s Up-C IPO in July 2024.
Client Highlights
10.02.25
Wilson Sonsini Advises Kodiak AI on Completed Business Combination with Ares Acquisition Corporation II
On September 29, 2025, Kodiak AI, a leading provider of AI-powered autonomous vehicle technology, announced that Kodiak Robotics, Inc. successfully completed its business combination with Ares Acquisition Corporation II (AACT), a publicly traded special purpose acquisition company. The business combination was approved by AACT shareholders on September 23, 2025. In connection with the closing, AACT was renamed Kodiak AI. Kodiak AI’s common stock and public warrants began trading on Nasdaq on September 25, 2025, under the ticker symbols “KDK” and “KDKRW,” respectively. Wilson Sonsini Goodrich & Rosati advised Kodiak AI on the transaction.
Client Highlights
6.20.25
Wilson Sonsini Advises Couchbase on $1.5 Billion Acquisition by Haveli Investments
Couchbase, the developer data platform for critical applications in AI, announced that it has entered into a definitive agreement to be acquired by Haveli Investments, a technology-focused investment firm, in an all-cash transaction valued at approximately $1.5 billion. Wilson Sonsini Goodrich & Rosati is advising Couchbase on the transaction.
Alerts
2.05.25
Delaware Supreme Court Issues Important Ruling Addressing Fiduciary Duties When Reincorporating out of Delaware
On February 4, 2025, the Delaware Supreme Court issued its much-anticipated decision in the TripAdvisor1 litigation addressing the standard of review that applies to a board’s decision to reincorporate from Delaware to another jurisdiction. The court determined that TripAdvisor’s proposed reincorporation from Delaware to Nevada should be reviewed under the business judgment standard of review, under which courts will defer to the judgment of boards and dismiss ensuing fiduciary duty claims from stockholders.
Client Highlights
1.13.25
Wilson Sonsini Advises Bolt Medical on Merger with Boston Scientific
On January 8, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease, for up to $900 million. Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction.
Client Highlights
12.20.24
Wilson Sonsini Advises Aadi Bioscience on $100 Million Sale of FYARRO®, $100 Million PIPE Financing and License Agreement for ADC Portfolio
On December 19, 2024, Aadi Bioscience announced that it had entered into an agreement to sell its commercial drug product FYARRO® to KAKEN Pharmaceutical for $100 million, an agreement to sell and issue $100 million of equity in a PIPE financing, and an exclusive license agreement for the development and global commercialization of a three-asset portfolio of preclinical, next-wave antibody-drug conjugates (ADCs), in collaboration with WuXi Biologics, a global Contract Research, Development and Manufacturing Organization, and Hangzhou DAC, a global leader in ADC innovation.
Client Highlights
11.25.24
Wilson Sonsini Advises GI Windows Surgical on $37 Million Series B
On November 20, 2024, Massachusetts-based GI Windows Surgical, a clinical-stage medical device company dedicated to developing the first fundamental breakthrough in anastomoses technology, announced the completion of a $37 million Series B financing round led by Orlando Health Ventures and joined by Rex Health Ventures with participation from existing investors including Johnson & Johnson Innovation–JJDC, JCInvestco, Fred Moll, MD, and an additional strategic investor. Wilson Sonsini Goodrich & Rosati advised GI Windows Surgical on the transaction.